SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-024692
Filing Date
2021-05-05
Accepted
2021-05-05 16:16:33
Documents
48
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_inmunebio.htm 10-Q 384722
2 CERTIFICATION f10q0321_ex31-1inmunebio.htm EX-31.1 10677
3 CERTIFICATION f10q0321_ex31-2inmunebio.htm EX-31.2 10807
4 CERTIFICATION f10q0321_ex32-1inmunebio.htm EX-32.1 4569
5 CERTIFICATION f10q0321_ex32-2inmunebio.htm EX-32.2 4556
  Complete submission text file 0001213900-21-024692.txt   2525830

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE inmb-20210331.xml EX-101.INS 268922
7 XBRL SCHEMA FILE inmb-20210331.xsd EX-101.SCH 42680
8 XBRL CALCULATION FILE inmb-20210331_cal.xml EX-101.CAL 23399
9 XBRL DEFINITION FILE inmb-20210331_def.xml EX-101.DEF 186459
10 XBRL LABEL FILE inmb-20210331_lab.xml EX-101.LAB 352172
11 XBRL PRESENTATION FILE inmb-20210331_pre.xml EX-101.PRE 187145
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 21893512
SIC: 2836 Biological Products, (No Diagnostic Substances)